Prof Philip Routledge - OBE
Telephone:+44 (0)29 207 42051
Prof Routledge is a member of staff in the Department of Pharmacology, Therapeutics & Toxicology within the School of Medicine, and brings to the School of Pharmacy and Pharmaceutical Sciences world-class research expertise in patient safety.
Current Research Interests
- Bespoke prescribing
- Drug safety and pharmacovigilance
- Management of drug toxicity
His group’s work on adjusting doses of warfarin and heparin and the use of intravenous vitamin K to moderate anticoagulant effect have been incorporated into UK national guidelines and are also used internationally. His group have published widely in the field of pharmacovigilance and drug safety, particularly in relation to the role of the yellow card system of surveillance of suspected adverse drug reactions. His group’s research has also been instrumental in the development and dissemination of UK national guidelines for the management of paracetamol (acetaminophen) poisoning. He was awarded SKF Prize in Clinical Pharmacology by the British Pharmacological Society in 1986 for his contribution to research in clinical pharmacology.
He has personally supervised 8 PhD students and 3 MD students, and has published over 200 articles, including original research papers, reviews and invited chapters, and has co-written or edited two books. He serves on the editorial board for Adverse Reactions and Acute Poisoning Reviews and the Adverse Drug Reactions Bulletin. Professor Routledge’s continuing contribution to clinical pharmacology has recently been recognised in the award of the Lilly Prize in Clinical Pharmacology in 2005, awarded by the British Pharmacological Society for distinction in clinical pharmacology over many years.